From January 1, 2022 to March 31, 2022, the company has repurchased 49,868 shares, representing 0.42% for KRW 4,745.81 million. With this, the company has completed the repurchase of 160,533 shares, representing 1.35% for KRW 19,650.63 million under the buyback announced on October 15, 2020.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
94,600 KRW | -6.89% |
|
-6.71% | -27.73% |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-27.73% | 932M | |
+16.50% | 42.2B | |
+20.78% | 21.24B | |
+21.14% | 15.89B | |
+23.69% | 14.91B | |
+57.44% | 13.1B | |
-0.05% | 6.79B | |
-14.94% | 6.24B | |
+21.38% | 6.08B | |
-8.87% | 5.73B |
- Stock Market
- Equities
- A185750 Stock
- News Chong Kun Dang Pharmaceutical Corp.
- Tranche Update on Chong Kun Dang Pharmaceutical Corp.'s Equity Buyback Plan announced on October 15, 2020.